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Correlation between High Resolution
Dynamic MR Features and Prognostic
Factors in Breast Cancer
Objective: To correlate high resolution dynamic MR features with prognostic
factors in breast cancer.
Materials and Methods: One hundred and ninety-four women with invasive
ductal carcinomas underwent dynamic MR imaging using T1-weighted three-
dimensional fast low-angle shot (3D-FLASH) sequence within two weeks prior to
surgery. Morphological and kinetic MR features were determined based on the
breast imaging and reporting data system (BI-RADS) MR imaging lexicon.
Histological specimens were analyzed for tumor size, axillary lymph node status,
histological grade, expression of estrogen receptor (ER), expression of proges-
terone receptor (PR), and expression of p53, c-erbB-2, and Ki-67. Correlations
between the MR features and prognostic factors were determined using the
Pearson 
2 test, linear-by-linear association, and logistic regression analysis. 
Results: By multivariate analysis, a spiculated margin was a significant, inde-
pendent predictor of a lower histological grade (p < 0.001), and lower expression
of Ki-67 (p = 0.007). Rim enhancement was significant, independent predictor of
a higher histological grade (p < 0.001), negative expression of ER (p = 0.001),
negative expression of PR (p < 0.001) and a larger tumor size (p = 0.006). A
washout curve may predict a higher level of Ki-67 (p = 0.05). Most of the parame-
ters of the initial enhancement phase cannot predict the status of the prognostic
factors. Only the enhancement ratio may predict a larger tumor size (p = 0.05).
Conclusion: Of the BI-RADS-MR features, a spiculated margin may predict
favorable prognosis, whereas rim enhancement or washout may predict unfavor-
able prognosis of breast cancer. 
ynamic contrast-enhanced magnetic resonance (MR) imaging has
emerged as a promising modality for the detection, diagnosis, and staging
of breast cancer. MR imaging provides important information not only on
the morphology of lesions but also on the functional aspects reflected by the temporal
and spatial uptake of contrast medium. Integration of both kinetic and morphological
features is important for accurate diagnosis (1, 2). In addition to these roles, the
relationship of MR features and prognostic factors of breast cancer recently have been
studied. However, these studies showed various results that might be due to variable
MR techniques and interpretation criteria (3 11). Moreover, to the best of our
knowledge, there has been only one study to correlate the MR features based on the
breast imaging and reporting data system (BI-RADS)-MR imaging lexicon (12) with
prognostic factors of breast cancer, but the study did not correlate various early phase
kinetic parameters (13).
The purpose of this study was to correlate MR features of invasive ductal carcinomas
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Daccording to the BI-RADS-MR imaging lexicon with
prognostic factors including tumor size, axillary lymph
node status, histological grade, estrogen receptor (ER),
progesterone receptor (PR), p53, c-erbB-2, and Ki-67.
MATERIALS AND METHODS
Patients
Between March 2004 and November 2004, 270 consecu-
tive patients with a histopathologically confirmed invasive
ductal carcinoma not otherwise specified (NOS) underwent
MR imaging within two weeks prior to surgery. Due to
having undergone a previous excisional biopsy, 47 patients
were excluded and 29 patients were excluded due to
previous neoadjuvant chemotherapy. The remaining 194
patients (age range 29 76 years, mean 47 years) consti-
tuted the study group. In patients with multifocal, multicen-
tric carcinoma, the largest lesion was analyzed. The institu-
tional review board of our institution approved the study
and informed consent was obtained from all patients.
MR Imaging
MR imaging was performed with a 1.5 T imager (Sonata;
Siemens Medical Systems, Erlangen, Germany). The
affected side of each patient was examined by using a
dedicated double-breast coil, with the patient in a prone
position. Dynamic contrast-enhanced images with one pre-
contrast and four post-contrast series were obtained, using
a T1-weighted three-dimensional fast low-angle shot (3D-
FLASH) sequence with fat suppression in a one-sided
sagittal plane (TR 4.9 ms, TE 1.8 ms, flip angle 12 , field of
view 170 mm, matrix 224 448, time of acquisition 84
seconds, 1.0 mm section thickeness with no gap). A bolus
of gadopentetate dimeglumine (Magnevist; Schering,
Berlin, Germany) was injected intravenously by hand at a
dose of 0.1 mmol per kilogram of body weight within 15
seconds, followed by a 20 mL saline solution flush.
Image Analysis
Post-processing subtraction of the dynamic images was
performed for all patients. We obtained two different
series of subtracted images for each patient: images
obtained before the administration of contrast material
were subtracted from the early phase (84 seconds) images
obtained after the administration of contrast material, and
delayed phase (336 seconds) images were subtracted from
the early phase postcontrast images. The first set of the
subtracted images showed early enhancement of the
lesions, and the second set showed temporal changes in the
enhancement pattern between each pair of early and
delayed phase images.
Two breast radiologists who were blinded to other
information retrospectively analyzed the images by
consensus according to the BI-RADS-MR imaging lexicon.
Abnormal enhancement was classified as mass or non-mass
enhancement. The shape of a mass was described as round,
oval, lobulated, or irregular. The margin of a mass was
described as smooth, irregular, or spiculated. The internal
enhancement pattern of a mass was described as homoge-
neous, heterogeneous, or rim enhancement. Signal intensi-
ties were obtained from the precontrast and each postcon-
trast series using operator-defined regions of interest (ROI).
Measurement was performed in at least three areas within
the tumor and the maximally enhancing ROI was selected
for analysis. The smallest possible pixel size (four pixels)
was used for the ROIs. The parameters of MR kinetics
were the enhancement ratio (signal intensity after contrast
injection baseline signal intensity/baseline signal intensity
100%), the peak time, the initial slope (enhancement
ratio/peak time), and the type of enhancement curve. The
curve shape rather than the absolute value of the enhance-
ment distinguished the type of enhancement curve. The
shape of the enhancement curve was described as persis-
tent, plateau, and washout. A persistent curve was continu-
ous enhancement increasing with time. A plateau curve
showed maximal signal intensity approximately 2 to 3
minutes after injection, and the signal intensity remained
constant at this level. A washout curve showed decreasing
signal intensity within 2 to 3 minutes after peak enhance-
ment.
Histopathological Analysis
Histopathological features were analyzed by one pathol-
ogist with 20 years of experience in the practice of breast
pathology. The tumor size, axillary lymph node status, and
histological grade were assessed as classical prognostic
factors (14). The Elston-Eillis method of tumor grading was
used for histological grading (15), in which a score of 1 3
was assigned for tubule formation, pleomorphism, and
mitotic count. The total score could range from 3 to 9, with
a total of 3 5 representative of grade 1, a total of 6 or 7
representative of grade 2, and a total of 8 or 9 representa-
tive of grade 3. 
The expression of ER, PR, c-erbB-2, the p53 tumor
suppressor gene, and Ki-67 were assessed as immunohisto-
chemical prognostic factors. A re-cut of the corresponding
paraffin block was immunostained with commercially
available antibodies to ER (Dako, Glostrup, Denmark), PR
(Dako, Glostrup, Denmark), c-erbB-2 (Novocastra,
Newcastle, UK), p53 (Dako, Glostrup, Denmark) and Ki-67
(Zymed, San Francisco, CA). The cutoff point for ER and
PR positive expression was 10%. Positive expression of
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nuclear staining. The c-erbB-2 expression was semiquantita-
tively assessed as follows: 0 for no membranous staining,
1+ for weak uneven membranous staining in some of the
tumor cells, 2+ for weak to moderate membranous staining
in a large number of tumor cells, and 3+ for distinctive
membranous staining in almost all of the tumor cells. The
cutoff point for Ki-67 positve expression was 20%.
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Table 1. Correlation between MR Findings and Classical Prognostic Factors
MR Findings
Tumor Size (cm) Lymph Node Status Histological Grade
2.0 2.1 5.0 > 5.0  0 1 34 9 1 0 123
Type
Mass 76 (39) 91 (47) 3 (2) 100 (52) 50 (26) 12 (6) 8 (4) 15 (8) 70 (36) 85 (44)
Non-Mass 14 (7) 10 (5) 17 (9) 5 (3) 1 (1) 1 (1) 8 (4) 16 (8)
P value 0.18 0.37 0.07
Shape of Mass
Oval 6 (4) 2 (1) 3 (2) 4 (2) 1 (1) 1 (1) 2 (1) 5 (3)
Lobulated 22 (13) 31 (18) 1 (1) 33 (19) 16 (9) 3 (2) 2 (1) 5 (3) 17 (10) 32 (19)
Irregular 48 (28) 58 (34) 2 (1) 64 (38) 30 (18) 8 (5) 6 (4) 9 (5) 51 (30) 48 (28)
P value 0.46 0.96 0.21
Margin of Mass
Irregular 42 (25) 61 (36) 2 (1) 64 (38) 31 (18) 7 (4) 3 (2) 4 (2) 29 (17) 72 (42)
Spiculated 34 (20) 30 (18) 1 (1) 36 (21) 19 (11) 5 (3) 5 (3) 11 (7) 41 (24) 13 (8)
P value 0.13 0.21 < 0.001
Internal Enhancement Pattern of Mass
Heterogeneous  48 (28) 36 (21) 2 (1) 53 (31) 20 (12) 6 (3) 7 (4) 8 (5) 54 (32) 24 (14)
Rim  28 (17) 55 (33) 1 (1) 47 (28) 30 (18) 6 (4) 1 (1) 7 (4) 16 (9) 61 (36)
P value 0.009 0.52 < 0.001
Curve Type
Persistent 9 (5) 4 (2) 8 (4) 3 (2) 2 (1) 9 (5) 4 (2)
Plateau 49 (25) 48 (25) 1 (1) 59 (30) 29 (15) 4 (2) 6 (3) 13 (7) 45 (23) 40 (21)
Washout 32 (17) 49 (25) 2 (1) 50 (26) 23 (12) 9 (5) 1 (1) 2 (1) 24 (12) 57 (29)
P value 0.02 0.56 < 0.001
Peak Time (sec)
84  21 (11) 30 (16) 29 (15) 17 (9) 5 (3) 3 (2) 17 (9) 31 (16)
168  46 (24) 52 (27) 3 (2) 61 (31) 27 (14) 6 (3) 7 (4) 8 (4) 36 (19) 57 (29)
252  14 (7) 15 (8) 19 (10) 8 (4) 2 (1) 4 (2) 16 (8) 9 (5)
336  9 (5) 4 (2) 8 (4.1) 3 (1.5) 2 (1.0) 9 (4.6) 4 (2.1)
P value 0.14 0.96 0.02
Enhancement Ratio*
100 10 (5) 6 (3) 12 (6) 3 (2) 1 (1) 3 (2) 7 (4) 6 (3)
101 150 28 (14) 17 (9) 22 (11) 19 (10) 2 (1) 2 (1) 5 (3) 19 (10) 21 (11)
151 200 22 (11) 30 (16) 1 (1) 32 (17) 13 (7) 6 (3) 2 (1) 3 (2) 24 (12) 26 (13)
201 250 20 (10) 33 (17) 1 (1) 33 (17) 15 (8) 3 (2) 3 (2) 3 (2) 19 (10) 32 (17)
> 250 10 (5) 15 (8) 1 (1) 18 (9) 5 (3) 1 (1) 2 (1) 1 (1) 9 (5) 16 (8)
P value 0.005 0.95 0.19
Initial Slope
1.0 43 (22) 33 (17) 1 (1) 50 (26) 21 (11) 2 (1) 4 (2) 11 (6) 37 (19) 29 (15)
1.1 1.5 25 (13) 33 (17) 1 (1) 31 (16) 17 (9) 7 (4) 4 (2) 25 (13) 34 (30)
1.6 2.0 9 (5) 12 (6) 1 (1) 12 (6) 9 (5) 1 (1) 2 (1) 5 (3) 15 (8)
2.1 2.5 5 (3) 9 (5) 9 (5) 2 (1) 3 (2) 1 (1) 4 (2) 9 (5)
> 2.5 8 (4) 14 (7) 15 (8) 6 (3) 1 (1) 1 (1) 7 (4) 14 (7)
P value 0.08 0.66 0.006
Note. Except for p values, data are number of lesions; data in parentheses are percentage.
* Signal intensity after contrast injection baseline signal intensity/baseline signal intensity  100%.
Enhancement ratio/peak time.
Linear-by-linear association test.Statistical Analysis
For univariate analysis, to test whether there was a
difference between categorical variables, the Pearson 
2-
test for two by two crosstabs and the linear-by-linear
association test for more than two variables in ordinal scale
were performed. In order to find the most significant and
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Table 2. Correlation between MR Findings and Immunohistochemical Prognostic Factors
MR Findings
ER PR p53 c-erbB-2 Ki-67
+ + + 0 1+ 2+ 3+ +
Type
Mass 107 (55) 63 (32) 101 (52) 69 (36) 49 (25) 121 (62) 101 (52) 35 (18) 15 (8) 19 (10) 102 (53) 68 (35)
Non-Mass 16 (8) 8 (4) 15 (8) 9 (5) 5 (3) 19 (10) 12 (6) 4 (2) 3 (2) 5 (3) 17 (9) 7 (4)
P value 0.72 0.77 0.41 0.16 0.31
Shape of Mass
Oval 3 (2) 5 (3) 2 (1) 6 (4) 3 (2) 5 (3) 4 (2) 2 (1) 2 (1) 5 (3) 3 (2)
Lobulated 29 (17) 25 (15) 29 (17) 25 (15) 14 (8) 40 (23) 35 (21) 8 (5) 6 (4) 5 (3) 32 (19) 22 (13)
Irregular 75 (44) 33 (19) 70 (41) 38 (22) 32 (19) 76 (45) 62 (37) 25 (15) 9 (5) 12 (7) 65 (38) 43 (25)
P value 0.01 0.02 0.96 0.92 1.00
Margin of Mass
Irregular 59 (35) 46 (27) 54 (32) 51 (30) 30 (18) 75 (44) 61 (36) 18 (11) 9 (5) 17 (10) 52 (31) 53 (31)
Spiculated 48 (28) 17 (10) 47 (28) 18 (11) 19 (11) 46 (27) 40 (24) 17 (10) 6 (4) 2 (4) 50 (29) 15 (9)
P value 0.02 0.007 0.93 0.07 < 0.001
Internal Enhancement Pattern of Mass
Heterogeneous 65 (38) 21 (12) 65 (38) 21 (12) 25 (15) 61 (36) 48 (28) 26 (15) 8 (5) 4 (2) 62 (37) 24 (14)
Rim  42 (25) 42 (25) 1 (1) 48 (28) 24 (14) 60 (35) 53 (31) 9 (5) 7 (4) 15 (9) 40 (24) 44 (26)
P value 0.001 <0.001 0.94 0.25 0.001
Curve Type
Persistent 8 (4) 5 (3) 7 (4) 6 (3) 5 (3) 8 (4) 7 (4) 3 (2) 2 (1) 1 (0) 10 (5) 3 (2)
Plateau 68 (35) 30 (16) 64 (33) 34 (18) 28 (14) 70 (36) 60 (31) 23 (12) 6 (3) 9 (5) 74 (38) 24 (12)
Washout 47 (24) 36 (19) 45 (23) 38 (20) 21 (11) 62 (32) 46 (24) 13 (7) 10 (5) 14 (7) 35 (18) 48 (25)
P value 0.19 0.35 0.36 0.18 < 0.001
Peak Time (sec)
84  26 (13) 25 (13) 24 (12) 27 (14) 15 (8) 36 (19) 34 (18) 8 (4) 9 (5) 22 (11) 29 (15)
168  71 (37) 39 (16) 64 (33) 37 (19) 25 (13) 76 (39) 54 (28) 21 (11) 14 (7) 12 (6) 63 (33) 38 (20)
252  18 (9) 11 (6) 21 (11) 8 (4) 9 (5) 20 (10) 18 (9) 7 (4) 2 (1) 2 (1) 24 (12) 5 (3)
336  8 (4) 5 (3) 7 (4) 6 (3) 5 (3) 8 (4) 7 (4) 3 (2) 2 (1) 1 (1) 10 (5) 3 (2)
P value 0.33 0.13 0.58 0.93 < 0.001
Enhancement Ratio*
100 9 (5) 7 (4) 8 (4) 8 (4) 7 (4) 9 (5) 9 (5) 4 (2) 1 (1) 2 (1) 9 (5) 7 (4)
101 150 28 (14) 17 (9) 26 (13) 19 (10) 11 (6) 34 (18) 26 (13) 14 (7) 1 (1) 4 (2) 30 (16) 15 (8)
151 200 36 (19) 17 (9) 34 (18) 19 (10) 16 (8) 37 (19) 34 (18) 8 (4) 5 (3) 6 (3) 34 (18) 19 (10)
201 250 36 (19) 18 (9) 35 (18) 19 (10) 14 (7) 40 (21) 26 (13) 10 (5) 9 (5) 9 (5) 29 (15) 25 (13)
> 250 14 (7) 12 (6) 13 (7) 13 (7) 6 (3) 20 (10) 18 (9) 3 (2) 2 (1) 3 (2) 17 (9) 9 (5)
P value 0.96 0.84 0.33 0.45 0.72
Initial Slope
1.0 52 (27) 25 (13) 48 (25) 29 (15) 22 (11) 55 (28) 43 (22) 20 (10) 5 (3) 9 (5) 58 (30) 19 (10)
1.1 1.5 40 (21) 19 (10) 39 (20) 20 (10) 16 (8) 43 (22) 32 (17) 11 (6) 11 (6) 5 (3) 33 (17) 26 (13)
1.6 2.0 11 (6) 11 (6) 12 (6) 10 (5) 8 (4) 14 (7) 15 (8) 2 (1) 2 (1) 3 (2) 11 (6) 11 (6)
2.1 2.5 7 (4) 7 (4) 6 (3) 8 (4) 2 (1) 12 (6) 11 (6) 3 (2) 7 (4) 7 (4)
> 2.5 13 (7) 9 (5) 11 (6) 11 (6) 6 (3) 16 (8) 12 (6) 6 (3) 4 (2) 10 (5) 12 (6)
P value 0.16 0.12 0.73 0.98 0.003
Note. Except for p values, data are number of lesions; data in parentheses are percentage.
* Signal intensity after contrast injection baseline signal intensity/baseline signal intensity  100%.
Enhancement ratio/peak time.
Pearson 
2-test.
Linear-by-linear association test.independent relationship, multivariate analyses were
performed. Variables found to be significant by univariate
analysis were tested in regression models. For dichotomous
dependent variables, a binary logistic regression with
forward-likelihood-ratio covariate selection method was
performed. Logistic regression was applied to analyze the
effects of the different MR parameters as follows. Tumor
size by grouping 2 cm or less than 2 cm versus more than 2
cm, by grouping the histological grade of grade 1 and
grade 2 lesions versus grade 3 lesions, by grouping expres-
sion of ER and PR positive versus negative, by grouping
the expression of c-erbB-2 with 0, 1+, 2+, versus the 3+
category, by grouping expression of p53 negative versus
positive, and by grouping Ki-67 negative versus positive.
A p value less than 0.05 was considered as statistically
significant. The statistical analyses were performed with
statistical software (SPSS for Microsoft Windows, version
10.0; SPSS, Chicago, IL).
RESULTS
Imaging Analysis
Of the 194 cases of invasive ductal carcinoma NOS,
there were 170 (88%) mass lesions and 24 (12%) non-
mass enhancement lesions. Of the 170 masses, there were
eight (5%) oval shape, 54 (32%) lobulated shape, and 108
(64%) irregular shape lesions. There were 105 (62%)
irregular margin, and 65 (38%) spiculated margin lesions.
There were 86 (51%) cases of heterogeneous enhance-
ment, and 84 (49%) cases of rim enhancement. Round
shape, smooth margin, and homogeneous enhancement
were not noted. Of the 194 invasive ductal carcinomas
NOS, the curve types were persistent in 13 (7%) lesions,
plateau in 98 lesions (51%), and washout in 83 (43%)
lesions. A peak time occurring at the first postcontrast
phase was seen for 51 (26%) lesions, at the second
Lee et al.
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Fig. 1. A 56-year-old woman with
invasive ductal carcinoma not otherwise
specified of histological grade 1, ER (+),
PR (+), Ki-67 ( ).
A. Sagittal standard subtracted fast low-
angle shot MR image shows an irregular
mass with a spiculated margin (arrow).
B. Sagittal reverse subtracted fast low-
angle shot MR image shows non-
washout kinetics (arrow).
C. Time-signal intensity curve shows
plateau late enhancement.
D. Photomicrograph shows high propor-
tional tubule formation, low nuclear
pleomorphism, and a low mitotic count
(Hematoxylin & Eosin staining,  400). 
AB
CDpostcontrast phase was seen for 101 (52%) lesions, at the
third postcontrast phase was seen for 29 (15%) lesions,
and at the fourth postcontrast phase was seen for 13 (7%)
lesions. 
The enhancement ratio ranged from 42 533% (mean
193  74%). The initial slope ranged from 0.22 6.35
(mean 1.36  0.84) (Tables 1, 2). 
Histopathological Analysis
Tumor size ranged from 0.1 6.0 cm (mean 2.2  1.0
cm). The number of axillary lymph node metastasis ranged
from 0 29 (mean 1.6). Of the tumors, 60% (117 of 194)
had no axillary lymph node metastasis and 29% (55 of
194) had one to three metastatic lymph nodes. Of the
tumors, 52% (101 of 194) were assessed as high grade and
48% (93 of 194) were low grade (Table 1). Of the tumors,
63% (123 of 194) were ER positive, 60% (116 of 194)
were PR positive, 72% (140 of 194) were p53 positive,
and 39% (75 of 194) were Ki-67 positive. In 58% (113 of
194) of the tumors no expression of c-erbB-2 protein was
evident, 20% (39 of 194) were 1+, 9% (18 of 194) were
2+, and 12% (24 of 194) were 3+ (Table 2). 
Statistical Analysis
By univariate analysis, the shape of the mass was signifi-
cantly associated with the ER (p = 0.01), and PR expres-
sion status (p = 0.02). The margin of mass was significantly
associated with the histological grade (p < 0.001), expres-
sion of ER (p = 0.02), expression of PR (p = 0.007), and Ki-
67 status (p < 0.001). The internal enhancement pattern
was significantly associated with tumor size (p = 0.009),
histological grade (p < 0.001), expression of ER (p =
0.001), expression of PR (p < 0.001) and Ki-67 status (p =
0.001). The curve type was significantly associated with
tumor size (p = 0.02), histological grade (p < 0.001) and
Ki-67 status (p < 0.001). Of the parameters of the initial
High Resolution Dynamic MRI Features and Prognostic Factors in Breast Cancer
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Fig. 2. A 48-year-old woman with
invasive ductal carcinoma not otherwise
specified of histological grade 3, ER ( ),
PR ( ), Ki-67 (+).
A. Sagittal standard subtracted fast low-
angle shot MR image shows a lobulated
mass with rim enhancement (arrow).
B. Sagittal reverse subtracted fast low-
angle shot MR image shows washout
kinetics (arrow).
C. Time-signal intensity curve shows
washout late enhancement.
D. Photomicrograph shows minimal
tubule formation, high nuclear pleomor-
phism, and a high mitotic count
(Hematoxylin & Eosin staining,  400). 
AB
CDphase, peak time was significantly associated with the
histological grade (p = 0.02) and Ki-67 status (p < 0.001).
The enhancement ratio was significantly associated with
tumor size (p = 0.005). The initial slope was significantly
associated with the histological grade (p = 0.006), and Ki-
67 status (p = 0.003). A correlation was not found between
MR features with lymph node status, p53 status and c-
erbB-2 status (Tables 1, 2).
Parameters found to be significant by univariate analysis
were selected for logistic regression analysis. The internal
enhancement pattern of mass, curve type, and enhance-
ment ratio entered into the regression model of tumor size.
The margin, internal enhancement pattern of mass, curve
type, peak time, and initial slope entered into the regres-
sion model of histological grade. The shape, margin, and
internal enhancement pattern of mass entered into the
regression model of ER and PR status respectively. The
margin, internal enhancement pattern of mass, curve type,
peak time, and initial slope entered into the regression
model of Ki-67 status. By multivariate analysis, spiculated
margin was a significant, independent predictor of a lower
histological grade (p < 0.001), and lower expression of Ki-
67 (p = 0.007) (Fig. 1). Rim enhancement was a significant,
independent predictor of a higher histological grade (p <
0.001), negative expression of ER (p = 0.001), negative
expression of PR (p < 0.001) (Fig. 2), and a larger tumor
size (p = 0.006). A washout curve may predict higher a Ki-
67 status (p = 0.05). An enhancement ratio more than
200% may predict a larger tumor size (p = 0.05) (Table 3).
DISCUSSION
In this study, a spiculated margin of breast cancer on
high spatial resolution dynamic MR was able to predict a
lower histological grade and lower Ki-67 status. This result
was consistent with previous studies. It is well-known that
high grade breast cancers show circumscribed margins
because of their high cellularity and rich hyaluronic acid
Lee et al.
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Table 3. Results of Logistic Regression Analysis*
Included Variables B**  S.E. Odds ratio P value
For Tumor Size
Rim enhancement 0.90 0.33 2.45 0.006
Enhancement ratio 0.05
101 150 0.46 0.69 1.58 0.51
151 200 1.19 0.68 3.28 0.08
201 250 1.48 0.68 4.39 0.04
> 250 1.59 0.76 4.91 0.04
For Histological Grade
Spiculated margin -1.83 0.40 0.16 < 0.001
Rim enhancement 1.50 0.37 4.46 < 0.001
For ER
Rim enhancement 1.13 0.33 3.01 0.001
For PR
Rim enhancement 1.42 0.33 4.13 < 0.001
For Ki-67
Spiculated margin -0.99 0.37 0.37 0.007
Curve type
Persistent curve 0.001
Plateau curve 0.45 0.83 1.57 0.59
Washout curve 1.65 0.83 5.23 0.05
Note. * Binary logistic regression with likelihood-ratio covariate selection method.
Dependent variable was tumor size with grouping  2 cm vs > 2 cm; independent variables were internal enhancement pattern of mass, curve type,
and enhancement ratio. 
Dependent variable was histological grade with grouping 1 and 2 vs 3; independent variables were margin of mass, internal enhancement pattern of
mass, curve type, peak time, and initial slope. 
Dependent variable was ER with grouping positive vs negative; independent variables were shape of mass, margin of mass, and internal enhancement
pattern of mass.
Dependent variable was PR with grouping positive vs negative; independent variables were shape of mass, margin of mass, and internal enhancement
pattern of mass.
Dependent variable was Ki-67 with grouping negative vs positive; independent variables were margin of mass, internal enhancement pattern of mass,
curve type, peak time, and initial slope.
** Regression coefficients.
Standard error of the estimate.extracelluar matrix and inflammatory host reaction,
whereas low grade cancers show a spiculated margin
because of their low cellularity, rich collagen matrix and
desmoplastic host reaction (16, 17). However, this finding
differed from that reported by Szabo et al. (4) who found
that there was no correlation between the margin of a
breast cancer and prognostic factors. This difference might
be due to the different resolution of the MR imaging.
Spatial resolution in this study (0.29 mm
2 pixel size, 1 mm
thickness, and unilateral sagittal scan) was higher than in
the Szabo et al. study (3.6 mm
2 pixel size, 2.2 mm thicke-
ness, bilateral axial scan). A high resolution image is
necessary for an accurate analysis of the margin.
Another important result of this study was that rim
enhancement was a significant, independent predictor of a
higher histological grade (p < 0.001), negative expression
of ER (p = 0.001), negative expression of PR (p < 0.001),
and a larger tumor size (p = 0.006). The mechanism of rim
enhancement of breast cancer as seen on MR imaging can
be explained by high angiogenesis in the periphery of the
tumor, central necrosis, and central desmoplasia (6, 18
20). There have been several studies showing a correlation
between rim enhancement and a higher histological grade,
negative expression of ER, higher expression of Ki-67,
lymph node status (4 6, 13), and the percentage of cells in
DNA-S phase, a measure of cellular proliferative activity
(21). Although Mussurakis et al. (3) reported that there
was no correlation between rim enhancement and
histopathological prognostic factors, results of this study
suggest that there is a correlation between rim enhance-
ment and poor prognostic factors. 
The parameters of the initial enhancement phase (2 to 3
minutes after contrast injection or when the curve starts to
change) had a role in the differentiation of benign and
malignant tumors of the breast. Faster and stronger
enhancement suggests a malignant lesion. However, there
has been a considerable overlap between benign and
malignant tumors in the initial enhancement parameters
(22). The parameter of delayed enhancement phase
determines the type of enhancement curve. In general,
benign lesions show a persistent curve and malignant
lesions show a washout curve, and a plateau curve can be
seen in both benign and malignant lesions (1, 2).
Controversies exist for the relationship between kinetic
parameters and prognostic factors. There have been
several reports about the significant correlation between
the enhancement ratio and the axillary lymph node status
or histological grade (7, 8) or high cellular proliferation (8).
There have been reports about a significant correlation
between washout and higher tumor grade (4, 8) or a higher
histological grade, positive Ki-67 (4, 6, 13), and negative
ER status (4). Tuncbilek et al. (11) also reported that
parameters of the initial enhancement phase were
correlated with grade. However, Stomper et al. (9)
reported that time-intensity curves showed no significant
correlation with pathological size, nodal status, or the
hormone receptor status of an invasive carcinoma. Fischer
et al. (10) reported that there was no correlation between
the enhancement ratio and the histological type of
carcinoma, grade, and lymph node status. Among these
kinetic parameters, our study demonstrated that the
washout curve was a significant, independent predictor of
Ki-67 positive expression, suggesting higher proliferative
activity and that most of parameters of initial enhancement
phase could not reflect prognostic factors.
This study has some limitations. First, we did not follow
patients. To draw a prognostic significance from our
analysis, follow-up of patients and multifactorial survival
analysis are required. Second, MR images were interpreted
by two observers in consensus, so interobserver variability
could not be determined.
There are some differences in this study from previous
studies. First, our study included only patients with
invasive ductal carcinoma NOS. Thus, we excluded bias
from the histopathological variability. Second, highly
spatial and temporal resolution images were obtained using
a 1.5 T dynamic 3D MR instrument, allowing the morpho-
logic and kinetic features of breast cancers to be meticu-
lously analyzed. Finally, we used the BI-RADS-MR
imaging lexicon enabling a standardized communication.
In conclusion, of the BI-RADS-MR features, a spiculated
margin may predict a favorable prognosis, whereas rim
enhancement and washout may predict an unfavorable
prognosis of breast cancer. These MR features can be used
to select subgroups of breast cancers with different biologi-
cal behavior.
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